• 1 800 260 6682
  • GTranslate

Other ways to reach us: 1.800.260.6682 | 902.424.8670 | info@investnovascotia.ca

Articles

Five Nova Scotia Start-Ups Selected for Latest GreenShoots Cohort

Tuesday, September 6, 2022

GreenShoots supports early stage companies in the agriculture, agri-food, bioeconomy, clean technology, and related sectors.

More Details

Arduro Sustainable Rubber: Using Clean Technology to Recycle Tires

Thursday, July 21, 2022

Arduro Sustainable Rubber has developed a clean technology process that turns waste tires back into high-grade, valuable raw materials.

More Details

Accelerate Highlights: Alan Uren, EndFirst Plans

Wednesday, June 29, 2022

EndFirst Plans have created OVERGantt, a project management software that solves the two critical factors in project success or failure – planning and communication.

More Details

GIT Announces Deal with Eastern Pacific Shipping

Wednesday, June 22, 2022

Graphite Innovation & Technologies (GIT) use graphene coatings to reduce corrosion and biofouling in water.

More Details

INTAG Bio Produces Plant Nutrients Sustainably

Tuesday, June 14, 2022

INTAG has developed technology to convert biological waste from fish and other animals into fertilizer.

More Details

Province Invests in Verschuren Centre Expansion

Thursday, June 9, 2022

The Province is investing in Nova Scotia's clean technology sector by supporting the Verschuren Centre for Sustainability in Energy and the Environment in Sydney to expand into a national biomanufacturing centre.

More Details

Innovacorp Wins Venture Capital Deal of the Year Award from CVCA

Thursday, May 19, 2022

Innovacorp has earned one of CVCA's most distinguished honours, Venture Capital Deal of the Year, for our investment in Meta Materials (META), a deal that resulted in a 35X return for us last year.

More Details

Pocket Finance Launches New Platform to Modernize Client Engagement for Financial Advisors

Wednesday, May 11, 2022

Pocket Finance is a platform that helps financial advisors and their customers improve engagement, data collection, and decision-making.

More Details

ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 Microspheres for Treatment of Liver Tumours

Tuesday, April 19, 2022

ABK Biomedical announced the first patient treated in ABK's First-in-Human study with Eye90 microspheres, a Y90 radioembolization device for the treatment of liver cancers.

More Details

Early Stage Commercialization Fund: 2021-2022 Funded Projects

Friday, April 8, 2022

Early Stage Commercialization Fund (ESCF) helps move Nova Scotia university, college and university-affiliated hospital research to market.

More Details

Pages